Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator <i>PHF19</i> As Marker of Aggressive Disease
Mike J. Mason(Sage Bionetworks), Justin Guinney(Sage Bionetworks), Pieter Sonneveld(Erasmus MC Cancer Institute), Alexander V. Ratushny(Center for Infectious Disease Research), Dirk Hose(Gavi), Aditya Pratapa(Virginia Tech), Yuanfang Guan(University of Michigan), Frank Schmitz, Fred K. Gruber(GNS Healthcare (United States)), Fadi Towfic, Andrew Dervan, Dan Rozelle(Rancho BioSciences (United States)), Yi Cui(Kunming University of Science and Technology), Anjan Thakurta(University of Oxford), Elias Chaibub Neto(Sage Bionetworks), Brian S. White(University of Utah), Mehmet Samur(Dana-Farber Cancer Institute), Brian A. Walker(University of Miami), Carolina Schinke(University of Arkansas for Medical Sciences), Boris Hayete(GNS Healthcare (United States)), Kenneth H. Shain(Moffitt Cancer Center), Daniel Auclair(Multiple Myeloma Research Foundation), Douglas E. Bassett, Hartmut Goldschmidt(Heidelberg University), Hervé Avet‐Loiseau(Institut universitaire du cancer de Toulouse Oncopole), Valeriy V. Lyzogubov(University of Arkansas for Medical Sciences), Thomas Yu(Sage Bionetworks), Christine Eng(Genome Institute of Singapore), Jonathan Göke(Genome Institute of Singapore), Matthew Trotter, Kamlesh Bisht, Samuel A. Danziger, Gareth J. Morgan(Hywel Dda University Health Board), Hongjie Chen(First Hospital of Lanzhou University), Bailiang Li(Stanford University), Hongyue Dai(Rosetta Stone (United States)), Nikhil Munshi(Johns Hopkins University), María Ortiz, Erin Flynt, William S. Dalton(Moffitt Cancer Center), Konstantinos Mavrommatis(Bristol-Myers Squibb (Germany))
Cited by 1
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k